The U.K.’s National Institute for Health and Care Excellence (NICE) recommends the use of pulsed field ablation as an option ...

The decision follows NICE’s review of safety and efficacy data, including clinical and economic analyses showing that PFA ...

The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...

Boston Scientific (NYSE: BSX) announced today that NICE issued guidance supporting the use of pulsed field ablation (PFA) for treating AFib.